Viewing Study NCT05027204


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-31 @ 4:20 AM
Study NCT ID: NCT05027204
Status: UNKNOWN
Last Update Posted: 2022-10-13
First Post: 2021-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module